INDRAYANI BIOTECH
|
INDRAYANI BIOTECH Last 5 Year Financial Ratios History
[Consolidated]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 1.40 | 2.55 | 1.30 | -3.25 | 2.22 |
| CEPS(Rs) | 3.12 | 4.46 | 1.49 | -3.14 | 5.00 |
| DPS(Rs) | - | - | - | - | - |
| Book NAV/Share(Rs) | 13.86 | 12.94 | 7.06 | 5.76 | 0.70 |
| Tax Rate(%) | 5.03 | 3.05 | - | - | - |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 14.23 | 10.62 | 11.01 | -23.44 | 5.56 |
| EBIT Margin(%) | 12.68 | 11.02 | 10.28 | -43.83 | 3.93 |
| Pre Tax Margin(%) | 6.60 | 7.55 | 7.21 | -53.18 | 1.62 |
| PAT Margin (%) | 6.27 | 7.32 | 7.21 | -53.18 | 1.62 |
| Cash Profit Margin (%) | 8.56 | 9.38 | 8.28 | -51.01 | 3.65 |
| Performance Ratios | |||||
| ROA(%) | 5.35 | 11.51 | 9.71 | -24.50 | 2.53 |
| ROE(%) | 19.41 | 34.86 | 20.23 | -112.29 | 43.42 |
| ROCE(%) | 14.40 | 22.45 | 16.38 | -23.16 | 7.85 |
| Asset Turnover(x) | 0.85 | 1.57 | 1.35 | 0.46 | 1.57 |
| Sales/Fixed Asset(x) | 2.20 | 3.03 | 3.47 | 1.20 | 4.07 |
| Working Capital/Sales(x) | 2.87 | 29.03 | -108.21 | -7.94 | 9.05 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.46 | 0.33 | 0.29 | 0.84 | 0.25 |
| Receivable days | 76.30 | 49.36 | 55.92 | 102.23 | 41.11 |
| Inventory Days | 59.91 | 15.40 | 7.77 | 53.33 | 37.10 |
| Payable days | 112.97 | 50.99 | 40.71 | 111.00 | 60.37 |
| Valuation Parameters | |||||
| PER(x) | 35.18 | 22.14 | 23.51 | - | 3.77 |
| PCE(x) | 15.74 | 12.66 | 20.47 | -2.02 | 1.67 |
| Price/Book(x) | 3.55 | 4.37 | 4.32 | 1.10 | 12.00 |
| Yield(%) | - | - | - | - | - |
| EV/Net Sales(x) | 1.99 | 1.61 | 1.96 | 1.74 | 0.31 |
| EV/Core EBITDA(x) | 13.31 | 12.04 | 17.25 | -7.82 | 5.17 |
| EV/EBIT(x) | 15.71 | 14.62 | 19.08 | -3.96 | 7.85 |
| EV/CE(x) | 1.89 | 2.23 | 2.35 | 0.91 | 0.30 |
| M Cap / Sales | 1.35 | 1.19 | 1.70 | 1.03 | 0.06 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 2.02 | 164.61 | 191.97 | -57.74 | -13.94 |
| Core EBITDA Growth(%) | 14.11 | 211.29 | 249.66 | -257.33 | 320.67 |
| EBIT Growth(%) | 17.39 | 183.55 | 168.48 | -571.81 | 362.02 |
| PAT Growth(%) | -12.64 | 168.74 | 139.59 | -1,489.05 | 1,346.41 |
| EPS Growth(%) | -45.24 | 96.79 | 139.92 | -246.65 | 1,346.41 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 1.71 | 1.17 | 0.74 | 0.79 | 54.18 |
| Current Ratio(x) | 1.67 | 1.08 | 0.97 | 0.78 | 1.40 |
| Quick Ratio(x) | 1.18 | 0.91 | 0.89 | 0.68 | 1.03 |
| Interest Cover(x) | 2.09 | 3.18 | 3.35 | -4.69 | 1.70 |
| Total Debt/Mcap(x) | 0.48 | 0.32 | 0.17 | 0.71 | 4.52 |
Compare Financial Ratios of peers of INDRAYANI BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDRAYANI BIOTECH | ₹223.1 Cr | 5.8% | -10.9% | -9.9% | Stock Analytics | |
| No other companies found in this Industry | ||||||
INDRAYANI BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDRAYANI BIOTECH | 5.8% |
-10.9% |
-9.9% |
| SENSEX | -1.4% |
3.3% |
25.2% |
You may also like the below Video Courses
